Pacira BioSciences Inc PCRX

NAS: PCRX | ISIN: US6951271005   30/04/2025
26,90 USD (-0,37%)
(-0,37%)   30/04/2025
Grafiek Pacira BioSciences Inc Grafiek Pacira BioSciences Inc

Pacira BioSciences Inc in het nieuws

21 april 2025 · DOMA Perpetual Supports Pacira's New $300 Million Share Repurchase Authorization as a Meaningful Step to Enhance Value for Shareholders · Persbericht

14 maart 2025 · DOMA Perpetual Nominates Three Highly Qualified Candidates for the Board of Pacira BioSciences · Persbericht

13 maart 2025 · SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pacira · Persbericht

12 maart 2025 · Class Action Filed Against Pacira BioSciences, Inc. (PCRX) - March 14, 2025 Deadline to Join - Contact Levi & Korsinsky · Persbericht

5 maart 2025 · SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pacira · Persbericht

4 maart 2025 · Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 14, 2025 in Pacira BioSciences, Inc. Lawsuit - PCRX · Persbericht

1 maart 2025 · PACIRA BIOSCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Pacira BioSciences, Inc. - PCRX · Persbericht

1 februari 2024 · G.O.A.T. Bowl I Registration Open to 4 Additional Pickleball Teams · Persbericht

17 november 2022 · New Research Reveals Common Treatments for Knee Pain are Falling Short, Placing Physical, Social, and Mental Burden on Patients · Persbericht

16 juni 2022 · National Safety Council and Pacira BioSciences Partner to Launch an Employee-Based Program Focused on Opioid Use and Misuse · Persbericht

Profiel Pacira BioSciences Inc

Fabricage van farmaceutische preparaten
Farmaceutische producten: Andere
Gezondheidstechnologie
Productie

Hoofdzetel: Parsippany, New Jersey vlag Verenigde Staten

CEO: David M. Stack

Werknemers: 778

Mijn selecties